@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_head { this: np:hasAssertion dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_assertion; np:hasProvenance dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_provenance; np:hasPublicationInfo dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_publicationInfo; a np:Nanopublication . dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_assertion a np:Assertion . dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_provenance a np:Provenance . dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_publicationInfo a np:PublicationInfo . } dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_assertion { miriam-gene:3439 a ncit:C16612 . lld:C0019189 a ncit:C7057 . dgn-gda:DGNc10890fc9575a89f0627ede50afa9dd5 sio:SIO_000628 miriam-gene:3439, lld:C0019189; a sio:SIO_001121 . } dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_provenance { dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_assertion dcterms:description "[Because 70% to 75% of patients with chronic hepatitis C either do not respond to or relapse after interferon (IFN) therapy, and because ursodeoxycholic acid (UDCA) has been shown to reduce aminotransferase levels in patients with chronic hepatitis, we undertook a prospective controlled randomized trial of IFN (group I) versus IFN plus UDCA (group II) in 80 patients with chronic hepatitis C. IFN was administered in both groups for 6 months (3 to 5 million units [MU] three times a week), and in group II UDCA (10 mg/kg/d) was administered with IFN and then alone for 3 additional months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:7843700; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP247751.RAgOFBqwVSMK9kW2fLr1IyFfyEhpMLHtRVNDSZP3ObkAo130_publicationInfo { this: dcterms:created "2014-10-02T12:34:18+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }